ZA200604971B - 3-Cyano-quinoline derivatives with antiproliferative activity - Google Patents
3-Cyano-quinoline derivatives with antiproliferative activityInfo
- Publication number
- ZA200604971B ZA200604971B ZA200604971A ZA200604971A ZA200604971B ZA 200604971 B ZA200604971 B ZA 200604971B ZA 200604971 A ZA200604971 A ZA 200604971A ZA 200604971 A ZA200604971 A ZA 200604971A ZA 200604971 B ZA200604971 B ZA 200604971B
- Authority
- ZA
- South Africa
- Prior art keywords
- cyano
- antiproliferative activity
- quinoline derivatives
- quinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP03/51059 | 2003-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200604971B true ZA200604971B (en) | 2009-05-27 |
Family
ID=34684508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200604971A ZA200604971B (en) | 2003-12-18 | 2006-06-15 | 3-Cyano-quinoline derivatives with antiproliferative activity |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US7655642B2 (de) |
| EP (1) | EP1696914B1 (de) |
| JP (1) | JP4892353B2 (de) |
| KR (1) | KR101158440B1 (de) |
| CN (1) | CN1893944B (de) |
| AR (1) | AR047060A1 (de) |
| AT (1) | ATE446750T1 (de) |
| AU (1) | AU2004298784B2 (de) |
| BR (1) | BRPI0417609B8 (de) |
| CA (1) | CA2549728C (de) |
| DE (1) | DE602004023876D1 (de) |
| EA (1) | EA200601176A1 (de) |
| ES (1) | ES2335216T3 (de) |
| HK (1) | HK1095742A1 (de) |
| IL (1) | IL176358A (de) |
| MX (1) | MXPA06007018A (de) |
| NO (1) | NO337622B1 (de) |
| NZ (1) | NZ547795A (de) |
| SG (1) | SG151288A1 (de) |
| TW (2) | TWI374879B (de) |
| UA (1) | UA83880C2 (de) |
| WO (1) | WO2005058318A1 (de) |
| ZA (1) | ZA200604971B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4892353B2 (ja) | 2003-12-18 | 2012-03-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗増殖活性を有する３−シアノ−キノリン誘導体 |
| JP4936897B2 (ja) | 2003-12-18 | 2012-05-23 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗増殖剤としてのピリド−およびピリミドピリミジン誘導体 |
| JO3088B1 (ar) * | 2004-12-08 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف |
| NI200700147A (es) | 2004-12-08 | 2019-05-10 | Janssen Pharmaceutica Nv | Derivados de quinazolina inhibidores de cinasas dirigidos a multip |
| MY169441A (en) | 2004-12-08 | 2019-04-11 | Janssen Pharmaceutica Nv | 2,4, (4,6) pyrimidine derivatives |
| KR101499594B1 (ko) | 2005-11-16 | 2015-03-09 | 씨티아이 바이오파마 코포레이션 | 산소가 결합된 피리미딘 유도체 |
| US10517876B2 (en) | 2005-11-16 | 2019-12-31 | Cti Biopharma Corp. | Oxygen linked pyrimidine derivatives |
| CA2654583C (en) | 2006-07-13 | 2015-11-24 | Janssen Pharmaceutica N.V. | Mtki quinazoline derivatives |
| WO2008087736A1 (ja) * | 2007-01-19 | 2008-07-24 | Ube Industries, Ltd. | アラルキルオキシ又はヘテロアラルキルオキシ基を有する芳香族アミンの製法 |
| AU2008265104B2 (en) * | 2007-06-21 | 2013-09-12 | Janssen Pharmaceutica Nv | Indolin-2-ones and aza-indolin-2-ones |
| CA2693715C (en) | 2007-07-27 | 2015-10-27 | Janssen Pharmaceutica Nv | Pyrrolopyrimidines |
| CN102127087B (zh) * | 2011-01-21 | 2012-07-04 | 江苏先声药物研究有限公司 | 喹唑啉衍生物 |
| MA39823A (fr) | 2014-04-03 | 2018-01-09 | Janssen Pharmaceutica Nv | Dérivés de pyridine macrocyclique |
| MA39822A (fr) | 2014-04-03 | 2018-02-06 | Janssen Pharmaceutica Nv | Dérivés de pyrimidine bicycle |
| BR112018006873A2 (pt) | 2015-10-05 | 2018-11-06 | The Trustees Of Columbia University In The City Of New York | ativadores do fluxo autofágico e fosfolipase d e depuração de agregados de proteína incluindo tau e tratamento de proteinopatias |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028613A (en) | 1990-02-16 | 1991-07-02 | Repligen Corporation | Novel pyrroloquinoline alkaloids and methods of use |
| US6002008A (en) * | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
| UA73073C2 (uk) | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
| US6288082B1 (en) * | 1998-09-29 | 2001-09-11 | American Cyanamid Company | Substituted 3-cyanoquinolines |
| UA72749C2 (en) | 1998-09-29 | 2005-04-15 | White Holdings Corp | Substituted 3-cyanoquinolines, a method for the preparation thereof (variants), pharmaceutical composition based thereon, a method for the treatment, inhibiting the growth or elimination of neoplasms and a method for the treatment, inhibiting progressing or elimination of polycystic kidney disease using them |
| IL164167A0 (en) * | 2002-03-30 | 2005-12-18 | Boehringer Ingelheim Pharma | 4-(N-phenylamino)-quinazolines/ quinolines as tyrosine kinase inhibitors |
| JO2785B1 (en) * | 2003-05-27 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinazoline derivatives |
| JP4892353B2 (ja) | 2003-12-18 | 2012-03-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗増殖活性を有する３−シアノ−キノリン誘導体 |
-
2004
- 2004-12-15 JP JP2006544439A patent/JP4892353B2/ja active Active
- 2004-12-15 EP EP04804849A patent/EP1696914B1/de active Active
- 2004-12-15 AT AT04804849T patent/ATE446750T1/de not_active IP Right Cessation
- 2004-12-15 WO PCT/EP2004/053497 patent/WO2005058318A1/en active Application Filing
- 2004-12-15 ES ES04804849T patent/ES2335216T3/es active Active
- 2004-12-15 KR KR1020067014235A patent/KR101158440B1/ko active IP Right Grant
- 2004-12-15 DE DE602004023876T patent/DE602004023876D1/de active Active
- 2004-12-15 SG SG200901893-8A patent/SG151288A1/en unknown
- 2004-12-15 AU AU2004298784A patent/AU2004298784B2/en active Active
- 2004-12-15 BR BRPI0417609A patent/BRPI0417609B8/pt active IP Right Grant
- 2004-12-15 EA EA200601176A patent/EA200601176A1/ru unknown
- 2004-12-15 US US10/596,509 patent/US7655642B2/en active Active
- 2004-12-15 UA UAA200607006A patent/UA83880C2/ru unknown
- 2004-12-15 CA CA2549728A patent/CA2549728C/en active Active
- 2004-12-15 MX MXPA06007018A patent/MXPA06007018A/es active IP Right Grant
- 2004-12-15 NZ NZ547795A patent/NZ547795A/xx unknown
- 2004-12-15 CN CN2004800375666A patent/CN1893944B/zh active Active
- 2004-12-17 TW TW093139380A patent/TWI374879B/zh active
- 2004-12-17 AR ARP040104751A patent/AR047060A1/es active IP Right Grant
- 2004-12-17 TW TW100107837A patent/TWI389890B/zh active
-
2006
- 2006-06-15 ZA ZA200604971A patent/ZA200604971B/xx unknown
- 2006-06-15 IL IL176358A patent/IL176358A/en active IP Right Grant
- 2006-07-18 NO NO20063324A patent/NO337622B1/no unknown
-
2007
- 2007-03-19 HK HK07102919.7A patent/HK1095742A1/xx unknown
-
2009
- 2009-11-24 US US12/624,708 patent/US8778920B2/en active Active
-
2013
- 2013-03-12 US US13/796,377 patent/US9040511B2/en active Active
-
2014
- 2014-05-23 US US14/285,760 patent/US9365517B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1095742A1 (en) | 3-cyano-quinoline derivatives with antiproliferative activity | |
| SI1583763T1 (sl) | Benzoazolilpiperazinski derivati, ki imajo VR1 antagonistično delovanje | |
| IL174533A0 (en) | Quinazoline derivatives as antiproliferative agents | |
| AP1850A (en) | Spiroindolineplperidine derivatives | |
| EG24050A (en) | Heterocylocarboxamide derivatives | |
| HK1077068A1 (en) | Azolidinone-vinyl fused-benzene derivatives | |
| EP1522540A4 (de) | Azaarenderivate | |
| PL375588A1 (en) | Pyrimido compounds having antiproliferative activity | |
| PL376475A1 (en) | N-substituted-2-oxodihydropyridine derivatives | |
| GB0317665D0 (en) | Qinazoline derivatives | |
| ZA200500471B (en) | N-biarylmethyl aminocycloalkanecarboxamide derivatives | |
| HK1086842A1 (en) | Macrolide-conjugates with anti-inflammatory activity | |
| AU2003222659A8 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
| DE60326941D1 (en) | Rs | |
| HK1099649A1 (en) | Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives 5-- | |
| EP1531854A4 (de) | O-derivatisierte nocathiacin-derivate | |
| GB0319793D0 (en) | Pyridinylmorpholine derivatives | |
| GB0213488D0 (en) | 2-Naphthamide derivatives | |
| MY144310A (en) | 3-cyano-quinoline deriatives with antiproliferative activity | |
| AU2003243397A8 (en) | Homo-camptothecin derivatives | |
| AU2003225764A8 (en) | Aza-thioxanthenones with antitumor activity | |
| AU2003224677A8 (en) | Aza-benzothiopyranoindazoles with antitumor activity | |
| GB0207572D0 (en) | Easy fit cill | |
| AU2003285777A8 (en) | 3-substituted-4-pyrimidone derivatives | |
| GB0210512D0 (en) | Tetrahydro-napthalene derivatives |